logo

LQDA

Liquidia·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

LQDA fundamentals

Liquidia (LQDA) released its earnings on Nov 3, 2025: revenue was 54.34M (YoY +1121.12%), beat estimates; EPS was -0.04 (YoY +86.67%), beat estimates.
Revenue / YoY
54.34M
+1121.12%
EPS / YoY
-0.04
+86.67%
Report date
Nov 3, 2025
LQDA Earnings Call Summary for Q3,2025
  • Commercial Success: YUTREPIA achieved 2,000+ prescriptions and 1,500+ patient starts with 85% pull-through rate, outperforming Tyvaso's growth.
  • Financial Discipline: $51.7M in sales with positive EBITDA and first positive cash flow month, balancing R&D investment.
  • Litigation Risk: Ongoing patent case with potential market exclusion or royalty risks.
  • Strategic Expansion: Planning trials in IPF/PPF and advancing L606 for 2026 growth.
EPS
Revenue

Revenue & Expenses

LQDA has released its 2025 Q3 earnings report, with revenue of 54.34M, reflecting a YoY change of 1121.72%, and net profit of -3.53M, showing a YoY change of 88.61%. The Sankey diagram below clearly presents LQDA's revenue sources and cost distribution.

Key Indicators

Liquidia (LQDA) key financial stats and ratios, covering profitability, financial health, and leverage.
Liquidia (LQDA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Liquidia (LQDA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Liquidia (LQDA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Liquidia (LQDA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Liquidia (LQDA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield